Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$656M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$612M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$353M |
| 5 |
Walmart
WMT
|
+$316M |
Top Sells
| 1 |
Apple
AAPL
|
+$483M |
| 2 |
PepsiCo
PEP
|
+$394M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$248M |
| 4 |
Philip Morris
PM
|
+$246M |
| 5 |
Eli Lilly
LLY
|
+$240M |
Sector Composition
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Millicom
TIGO
$7.96B
| $759K | ﹤0.01% |
15,600
+200
| +1% | +$9.73K |
|
2702
AMREP Corp
AXR
$127M
| $756K | ﹤0.01% |
132,280
+5,700
| +5% | +$32.6K |
|
2703
Invesco Senior Loan ETF
BKLN
$6.8B
| $753K | ﹤0.01% |
33,346
-410,454
| -92% | -$9.27M |
|
|
BLPH
2704
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $751K | ﹤0.01% |
103,854
+8,218
| +9% | +$59.4K |
|
2705
ProShares Trust Short MSCI Emerging Markets
EUM
$8.59M
| $749K | ﹤0.01% |
19,563
+11,913
| +156% | +$456K |
|
2706
ESCO Technologies
ESE
$5.37B
| $748K | ﹤0.01% |
+9,400
| New | +$748K |
|
2707
iShares US Financials ETF
IYF
$4.04B
| $747K | ﹤0.01% |
11,600
+1,200
| +12% | +$77.3K |
|
|
SIFY
2708
Sify Technologies
SIFY
$871M
| $746K | ﹤0.01% |
88,122
+1,117
| +1% | +$9.46K |
|
2709
Inspired Entertainment
INSE
$251M
| $745K | ﹤0.01% |
103,570
+6,300
| +6% | +$45.3K |
|
|
UN
2710
DELISTED
Unilever NV New York Registry Shares
UN
| $744K | ﹤0.01% |
12,400
-297,200
| -96% | -$17.8M |
|
2711
Lendway
LDWY
$9.11M
| $740K | ﹤0.01% |
107,941
+443
| +0.4% | +$3.04K |
|
2712
eXp World Holdings
EXPI
$1.8B
| $739K | ﹤0.01% |
176,258
+139,458
| +379% | +$585K |
|
2713
Ironwood Pharmaceuticals
IRWD
$208M
| $739K | ﹤0.01% |
+86,053
| New | +$739K |
|
2714
SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$9.1B
| $738K | ﹤0.01% |
23,600
-3,800
| -14% | -$119K |
|
2715
Virco
VIRC
$126M
| $738K | ﹤0.01% |
191,600
+1,000
| +0.5% | +$3.85K |
|
|
STKL
2716
SunOpta
STKL
$758M
| $734K | ﹤0.01% |
407,648
-88,852
| -18% | -$160K |
|
2717
Yatra Online
YTRA
$92.9M
| $734K | ﹤0.01% |
178,100
-20,200
| -10% | -$83.3K |
|
|
OBSV
2718
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $733K | ﹤0.01% |
88,000
+8,400
| +11% | +$70K |
|
|
LTS
2719
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $729K | ﹤0.01% |
307,695
-147,705
| -32% | -$350K |
|
|
KG
2720
Kestrel Group, Ltd.
KG
$211M
| $724K | ﹤0.01% |
48,275
-3,570
| -7% | -$53.5K |
|
2721
SI-BONE Inc
SIBN
$653M
| $723K | ﹤0.01% |
+40,900
| New | +$723K |
|
2722
Limbach Holdings
LMB
$1.2B
| $721K | ﹤0.01% |
146,332
-25,028
| -15% | -$123K |
|
2723
Tantech Holdings
TANH
$3.21M
| $721K | ﹤0.01% |
48
+23
| +92% | +$345K |
|
2724
BGSF Inc
BGSF
$84.2M
| $720K | ﹤0.01% |
37,700
-16,900
| -31% | -$323K |
|
2725
Reinsurance Group of America
RGA
$12.5B
| $719K | ﹤0.01% |
4,500
-67,600
| -94% | -$10.8M |
|